Aptevo Therapeutics Inc. (APVO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.61
0.06 (1.32%)
At close: Jan 15, 2025, 3:59 PM
4.77
3.47%
After-hours Jan 15, 2025, 04:50 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 16.90M | 22.64M | 45.04M | 39.98M | 12.45M | 30.64M | 7.09M | 9.68M | 4.64M | 3.59M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 73.69M | 44.85M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 7.50M | 7.45M | -17.37M | n/a | n/a | n/a |
Other Long-Term Assets | n/a | -6.76M | 68.00K | 746.00K | 11.30M | 8.35M | 10.00M | n/a | -2.86M | n/a |
Receivables | n/a | 2.50M | 3.66M | 2.37M | n/a | 5.22M | 2.14M | 307.00K | 7.83M | 15.13M |
Inventory | n/a | 1.57M | 3.08M | 4.78M | 6.14M | 1.78M | 1.03M | 6.64M | 20.32M | 17.63M |
Other Current Assets | 2.16M | 2.31M | 3.86M | 4.92M | 11.41M | 11.05M | 11.13M | 16.12M | 2.34M | 5.20M |
Total Current Assets | 19.07M | 27.45M | 52.57M | 47.26M | 30.00M | 48.69M | 95.08M | 71.41M | 35.13M | 41.55M |
Property-Plant & Equipment | 5.78M | 6.76M | 3.96M | 5.54M | 7.69M | 5.20M | 5.84M | 5.91M | 4.18M | 3.20M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | 4.42M | 5.25M | 6.08M | 14.53M | 73.14M | 75.22M |
Total Long-Term Assets | 5.78M | 6.76M | 4.03M | 6.28M | 23.41M | 18.80M | 21.92M | 20.44M | 77.32M | 78.42M |
Total Assets | 24.84M | 34.22M | 56.60M | 53.55M | 53.41M | 67.49M | 117.01M | 91.86M | 112.46M | 119.97M |
Account Payables | 3.98M | 3.50M | 3.46M | 5.58M | 6.43M | 11.67M | 7.35M | 10.52M | 10.08M | 11.47M |
Deferred Revenue | n/a | -3.50M | -3.46M | -5.58M | -3.75M | n/a | -7.35M | 811.00K | 3.84M | 880.00K |
Short-Term Debt | n/a | 2.00M | 11.67M | 5.00M | 19.86M | n/a | 3.33M | n/a | n/a | n/a |
Other Current Liabilities | 3.24M | 3.21M | 19.63M | 3.96M | 11.95M | 5.94M | 7.83M | 8.21M | 6.02M | 7.48M |
Total Current Liabilities | 7.22M | 8.71M | 34.76M | 14.54M | 38.24M | 17.61M | 18.51M | 19.54M | 19.94M | 19.84M |
Long-Term Debt | 5.40M | 7.54M | 5.05M | 22.41M | 3.33M | 19.28M | 15.73M | 18.38M | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 15.58M | n/a | n/a | 200.00K | 734.00K | 469.00K | 71.00K | n/a |
Total Long-Term Liabilities | 5.40M | 7.54M | 20.63M | 22.41M | 3.33M | 19.48M | 16.46M | 21.75M | 3.90M | 5.53M |
Total Liabilities | 12.62M | 16.24M | 55.38M | 36.95M | 41.57M | 37.09M | 34.97M | 41.29M | 23.84M | 25.36M |
Total Debt | 5.40M | 9.54M | 16.71M | 27.41M | 23.19M | 19.28M | 19.06M | 18.38M | n/a | n/a |
Common Stock | 61.00K | 48.00K | 47.00K | 46.00K | 45.00K | 23.00K | 22.00K | 20.00K | 320.61M | 267.28M |
Retained Earnings | -223.45M | -206.04M | -214.06M | -185.61M | -167.86M | -127.41M | -73.72M | -80.69M | -231.99M | -172.67M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -105.00K | -33.00K | -5.86M | -5.33M |
Shareholders Equity | 12.22M | 17.97M | 1.22M | 16.59M | 11.84M | 30.41M | 82.03M | 50.57M | 88.62M | 94.61M |
Total Investments | n/a | n/a | n/a | n/a | 7.50M | 7.45M | 73.69M | 44.85M | n/a | n/a |